Photoactivation of the cGAS-STING pathway and pyroptosis by an endoplasmic reticulum-targeting ruthenium( ii ) complex for cancer immunotherapy
- 31 January 2025
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Inorganic Chemistry Frontiers
- Vol. 12 (6) , 2294-2302
Abstract
Three multifunctional ruthenium(II) complexes (Ru1–Ru3) modified with cholic acid were synthesized, which exhibited excellent singlet oxygen-generating ability and near-infrared (NIR) aggregation-induced emission (AIE) phosphorescence activity. Cellular toxicity assays revealed that Ru1 displayed pronounced phototoxicity against both human breast cancer cells (MDA-MB-231) and murine breast cancer cells (4T1), achieving a maximum phototoxicity index (PI) of 83.3. Mechanistic studies indicated that Ru1 exhibited superior targeting affinity for the endoplasmic reticulum (ER). Upon irradiation at 450 nm, it stimulated the production of reactive oxygen species (ROS) and initiated ER stress. This stress activated the interferon gene stimulator (STING) pathway's signaling cascade within the ER, prompting a Golgi apparatus response. The consequent activation induced pyroptosis and sequentially engaged the downstream proteins p-TBK1 and p-IRF3 within the STING pathway, thus promoting the secretion of antitumor cytokines and the elicitation of tumor immune responses. In vivo experiments conducted on Balb/c mice have demonstrated significant anti-tumor immune effects exhibited by Ru1. In summary, the immune modulation and targeted intervention by metal complexes represent an innovative and promising therapeutic strategy for cancer. This approach is anticipated to yield new perspectives for the development of metal complexes that augment tumor immunotherapy.Keywords
Funding Information
- National Natural Science Foundation of China (22477081)
- National Natural Science Foundation of China (22107074)
- Shenzhen Science and Technology Innovation Program (JCYJ20230808105913028)
- Department of Education of Guangdong Province (2024KCXTD012)
This publication has 47 references indexed in Scilit:
- Self-assembly of a ruthenium-based cGAS-STING photoactivator for carrier-free cancer immunotherapyEuropean Journal of Medicinal Chemistry, 2024
- Endoplasmic Reticulum‐Targeting Iridium(III) Nanosonosensitizer Amplifies Immunogenic Cell Death for Boosted Tumor Sono‐ImmunotherapyAdvanced Functional Materials, 2024
- Novel Pt(IV) complex OAP2 induces STING activation and pyroptosis via mitochondrial membrane remodeling for synergistic chemo-immunotherapyActa Pharmaceutica Sinica B, 2023
- Activated Natural Killer Cells‐Dependent Dendritic Cells Recruitment and Maturation by Responsive Nanogels for Targeting Pancreatic Cancer ImmunotherapySmall, 2022
- Pyroptosis Remodeling Tumor Microenvironment to Enhance Pancreatic Cancer Immunotherapy Driven by Membrane Anchoring PhotosensitizerAdvanced Science, 2022
- Near‐Infrared II Nanoadjuvant‐Mediated Chemodynamic, Photodynamic, and Photothermal Therapy Combines Immunogenic Cell Death with PD‐L1 Blockade to Enhance Antitumor ImmunitySmall, 2022
- An Endoplasmic Reticulum Specific Pro‐amplifier of Reactive Oxygen Species in Cancer CellsAngewandte Chemie International Edition, 2021
- Mitoxantrone triggers immunogenic prostate cancer cell death via p53-dependent PERK expressionCellular Oncology, 2020
- Necroptosis Induced by Ruthenium(II) Complexes as Dual Catalytic Inhibitors of Topoisomerase I/IIAngewandte Chemie International Edition, 2020
- Novel ruthenium(II) triazine complex [Ru(bdpta)(tpy)]2+ co-targeting drug resistant GRP78 and subcellular organelles in cancer stem cellsEuropean Journal of Medicinal Chemistry, 2018